Aim:

Future Perspectives of Medical, Pharmaceutical and Environmental Biotechnology is a peer-reviewed, open-access journal dedicated to promoting field-based activities in both developing and developed countries. It serves as a unique forum for the exchange of ideas across various fields, including health, pharmaceuticals, environment, and medical research. Additionally, the journal aligns with the sustainability goals outlined in Egypt's Vision 2030.

Objectives:

• Facilitate Field-Based Communication: FPME Journal's primary objective is to facilitate communication among field researchers by providing a platform to share best practices and lessons learned from their programs, especially those implemented in developing countries. The journal recognizes the importance of addressing issues related to health, the environment, pharmaceuticals, and biotechnology through field-based activities.
• Promote Best Practices Sharing: The journal aims to be an independent platform for key players in the development sector to share best practices, express viewpoints, share experiences, and collaborate with international development actors worldwide. It welcomes contributions relevant to the Middle East region and publishes research on environmental challenges, biomedical experiences, clinical investigations, and pharmaceutical research in the region.
• Encourage Research on Traditional Medicines: FPME Journal encourages research on the biological effects of traditional medicines and pharmacological and physiological interventions. It welcomes studies that focus on designing and developing new protocols, reporting standards, processes, methods, pharmaceutics, quality control, instruments, clinical practices, and their translation into healthcare systems.
• Support Innovation and Knowledge Dissemination: The journal is committed to promoting researchers with a wealth of knowledge to generate new ideas, and problem-solving models, and disseminate world-class research findings for the benefit of academia, industry, and policymakers. It strives to foster innovation and contribute to the advancement of science and technology.
• Promote Interdisciplinary Research: FPME Journal aims to bridge the gap between pharmaceutical, medical, and environmental biotechnology by encouraging interdisciplinary collaboration among researchers. We provide a space for scholars to exchange ideas and explore innovative solutions to address complex challenges in healthcare and environmental sustainability.
• Address Emerging Issues: FPME Journal seeks to address emerging issues and trends in pharmaceutical, medical, and environmental biotechnology. We encourage the submission of research that explores novel approaches, technologies, and solutions to address contemporary global challenges.
• Facilitate Global Collaboration: We strive to create a global platform that facilitates collaboration and knowledge exchange among researchers, institutions, and industries. Our journal welcomes contributions from researchers worldwide, promoting a diverse and inclusive scientific community.
• Support Sustainability and Public Health: FPME Journal recognizes the critical role of biotechnology in promoting sustainability and improving public health, a key aspect of Egypt's Vision 2030. We aim to publish research that contributes to the development of eco-friendly technologies and healthcare solutions for the benefit of society and the environment.

During the initial stages, will cover primarily areas related to health, pharmaceutics, and the Environment. Suitable topics for this journal include, but are not limited to:

• Small molecules as drug candidates: drug discovery, drug design, medicinal chemistry, combinatorial chemistry, structure-property correlations molecular modeling, pharmacophore, and bioinformatics.
• Biomolecules, natural products, phages, and cells as therapeutic tools: peptides, aptamers, glycans, antibodies, extracts, bacteriophages, and stem cells.
• Biological targets and biomarkers: enzymes, receptors, membranes, genes, ion channels, inhibitors, agonists, antagonists, neurons, binding affinity, biofilms, bacteria, viruses, parasites, and protein–protein interactions.
• Pharmacokinetics and pharmacodynamics: pharmaceutical analyses, drug effects, ADME, animal experimentation, and clinical trials.
• Pharmaceutical preparations and drug delivery: dosage form design, bioconjugates, prodrugs, formulation, metabolites, nanomaterials, nanomedicines, and drug targeting.
• Pathogenesis and mechanisms of diseases
• Translational medical research
• Biomaterial in biomedical research
• Novel targets in various therapeutic areas: cardiovascular, vascular, hematology, oncology, neurology, orthopedics, dermatology, ophthalmology
• Biopharmaceutical biomedicine: biologics, and biosimilars
• Nanobiotechnological advances in biomedicine: nanomedicine, nanoscaffold implants (synthetic vascular graft), biosensors, bioimaging, gene therapy, vaccine, cell therapy, and tissue engineering.
• Ecology, biodiversity, biotic and abiotic stresses
• Conservation and restoration of degraded ecosystems (atmospheric, agriculture, marine, forestry)
• Environmental toxicology and human health
• Water and wastewater treatment and management (emerging contaminants, nanoparticles, microplastics, etc.)
• Environmental soil science and Land Contamination
• Emissions and air pollution management
• Renewable energy, and climate change
• Nature-based solutions and biomass valorization
• Solid, hazardous, and industrial waste management
• Urban environmental problems

In summary, the FPME Journal is dedicated to advancing scientific knowledge, promoting ethical research practices, and contributing to the realization of Egypt's Vision 2030 objectives for sustainability through the publication of high-quality research in the fields of pharmaceutical, medical, and environmental biotechnology. We invite researchers, scholars, and practitioners to join us in our mission to shape the future of these critical disciplines while supporting the sustainability development goals.